Market Access
Is the Digital Health Formulary a Rising Tide?
One of the earliest formularies on record is the 1816 Pharmacopoeia of the New York ...
How Safe are Safe Harbor Regulations?
The phrase “no more rebates” and recent guidance from the Department of Health and ...
Drug Pricing Regulatory Action Near Certain
It is never a good sign when reputational polls show that your industry ranks ...
Hub Services Offer Big Benefits for Retail Launch Brands
Along with their specialty brand counterparts, retail brands are starting to experience the pain ...
One PBM Executive’s Reaction to Recent Hearings on Capitol Hill
Earlier this month, top executives from pharmacy benefit managers (PBMs) Express Scripts, CVS Caremark, ...
Dealing with Insurers’ Copay Accumulators
Over the past couple of years, more and more insurers have started to implement ...
The Scrutiny on Rebates and Prices Will Change the Pharma-Payer Relationship
The government is the largest payer in the U.S. through Medicare and Medicaid, and ...
Four Key Questions About Payer Strategies in 2019
PM360 asked those with expertise in payer strategies how changes are impacting pharma’s relationship ...
From Capitol Hill to the Oval Office: What Washington Has in Store for Pharma and Healthcare Communications in 2019
With 71% of voters citing it as their foremost concern, healthcare was among the ...
Healthcare’s Financial Literacy Gap
A 2016 Harris Poll survey offered this shocking insight: The number of people who ...
Engagement Strategy with IHS & IDNs
Clinical pathways are formalized processes of care designed to reduce treatment variability. They can ...
Psoriasis Treatment: Unmet Needs Present 2019 Opportunities
Psoriasis and related conditions represent as an evolving treatment domain for many pharmas—and obvious ...
Learning to Speak HEOR
As one formulary decision-maker told us: “Recent regulation guidance on FDAMA114 frees up pharma ...